Quarterly Result30 May 2026, 04:31 pm
KMS Medisurgi: Standalone Audited Results for FY26
AI Summary
KMS Medisurgi Ltd has submitted its standalone audited financial results for the year ended March 31, 2026, as per SEBI regulations. The board approved the results along with the Independent Auditors Report, which includes a qualified opinion due to concerns regarding Post-Employment Benefits and stock records. The auditor's qualified opinion highlights a departure from AS-15 on Employee Benefits due to the lack of an actuarial report for Post-Employment Benefits and other long-term employee benefits. Additionally, the company is in the process of reconciling stock records, with a closing stock valued at ₹253.80 Lacs.
Key Highlights
- KMS Medisurgi releases standalone audited financial results for FY26.
- Auditor issues a qualified opinion due to Post-Employment Benefits accounting.
- Departure from AS-15 on Employee Benefits due to lack of actuarial report.
- Stock records reconciliation is in process; closing stock valued at ₹253.80 Lacs.
- Results approved in compliance with SEBI (LODR) Regulations, 2015.
Price Impact
More from KMSMEDI